# ClinicalTrials.gov record NCT02157974

> PeptideScanner retained ClinicalTrials.gov record NCT02157974 at 2026-07-30T18:43:56.184Z. Its registry update date was 2024-06-04, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct02157974-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-06-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02157974-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02157974-exenatide-v1.json
- Content SHA-256: `a7593b5fb4cb0ea0844b4263b03e2792426c152b1fed003904e502461a5886fd`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02157974 ([`ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5`](#source-ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02157974 at 2026-07-30T18:43:56.184Z. Its registry update date was 2024-06-04, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5`](#source-ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02157974 at 2026-07-30T18:43:56.184Z. Its registry update date was 2024-06-04, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5`](#source-ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5`](#source-ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5))

## Sources

<a id="source-ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5"></a>
- **ClinicalTrials.gov record NCT02157974 · retained source version 2024-06-04:192bb9d1aaf5d4faadc91b8c8f8c70c25e78419ac8286f0bbc83959cd9fe4ac1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02157974) (`ctg-observation-nct02157974-2024-06-04-192bb9d1aaf5`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02157974." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02157974-exenatide-v1.json SHA-256: a7593b5fb4cb0ea0844b4263b03e2792426c152b1fed003904e502461a5886fd.